Ajooni Biotech
FMCG
AJOONI NSE
₹2.88 No trade today
- P/E
- 12.52
Close 4 Nov 2026 ₹2.88 −2.06 −41.7% 1Y
Start ₹4.94
Key Fundamentals
MicrocapFood ProductsFMCGPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 6.11%
- Debt to Equity
- 0.20
- EPS (TTM)
- ₹0.23
- Book Value
- ₹5.24
- Market Cap
- —
- P/E (TTM)
- 12.52
- P/B
- 0.55
- ROE
- 4.28%
- Dividend Yield
- 0.00%
- EBITDA
- ₹8.70 Cr
- 52W High
- ₹5.50
- 52W Low
- ₹2.68
- Volume
- 0
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
52 Average
Data confidence 100/100
Category scores
- Quality
- 43
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 50
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 98
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 69
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 13
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Stock is trading at 0.57 times its book value
- Company is expected to give good quarter
- Debtor days have improved from 48.9 to 35.8 days.
- Company's working capital requirements have reduced from 128 days to 92.8 days
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 30.5%
- Company has a low return on equity of 4.02% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 6 | 2 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Bearish
1
Neutral
6
Bullish
2
Overall
Strong Bearish
Bearish
11
Neutral
6
Bullish
2
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 38.09
- Neutral
- MACD (12,26,9)
- −0.10
- Bullish
- SMA (50)
- 3.24
- Bearish
- SMA (200)
- 3.91
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +30.20% |
|---|---|
| 5Y | +28.97% |
| 3Y | +34.98% |
| 1Y | +58.26% |
| TTM | +78.40% |
Net profit
| 10Y | Zero base |
|---|---|
| 5Y | Zero base |
| 3Y | +58.74% |
| 1Y | +33.33% |
| TTM | +7.90% |
Operating cash flow
| 10Y | Outflow widened by ₹5 Cr |
|---|---|
| 5Y | Turned negative |
| 3Y | Outflow unchanged |
| 1Y | Outflow narrowed by ₹26 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +3.30 pp |
|---|---|
| 5Y | −0.62 pp |
| 3Y | −0.75 pp |
| 1Y | −0.18 pp |
| TTM | +0.52 pp |
Revenue by year
| Mar 2017 | ₹29.00 Cr |
|---|---|
| Mar 2018 | ₹42.00 Cr |
| Mar 2019 | ₹40.00 Cr |
| Mar 2020 | ₹40.00 Cr |
| Mar 2021 | ₹51.00 Cr |
| Mar 2022 | ₹74.00 Cr |
| Mar 2023 | ₹74.00 Cr |
| Mar 2024 | ₹80.00 Cr |
| Mar 2025 | ₹115 Cr |
| Mar 2026 | ₹182 Cr |
Net profit by year
| Mar 2017 | ₹0.00 Cr |
|---|---|
| Mar 2018 | ₹0.00 Cr |
| Mar 2019 | ₹0.00 Cr |
| Mar 2020 | ₹0.00 Cr |
| Mar 2021 | ₹0.00 Cr |
| Mar 2022 | ₹1.00 Cr |
| Mar 2023 | ₹1.00 Cr |
| Mar 2024 | ₹2.00 Cr |
| Mar 2025 | ₹3.00 Cr |
| Mar 2026 | ₹4.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21 | 19.48 | 20.05 | 19.58 | 25.66 | 25.72 | 34.03 | 29.27 | 31.27 | 31.74 | 58.75 | 60.62 | 63.49 |
| Expenses | 20.34 | 18.85 | 20.7 | 17.99 | 24.7 | 24.95 | 33.1 | 28.26 | 30.56 | 30.24 | 55.72 | 59.61 | 61.82 |
| Operating Profit | 0.66 | 0.63 | −0.65 | 1.59 | 0.96 | 0.77 | 0.93 | 1.01 | 0.71 | 1.5 | 3.03 | 1.01 | 1.67 |
| OPM % | 3.14% | 3.23% | −3.24% | 8.12% | 3.74% | 2.99% | 2.73% | 3.45% | 2.27% | 4.73% | 5.16% | 1.67% | 2.63% |
| Other Income | 0.07 | 0.29 | 1.57 | 0.26 | 0.04 | 0.31 | 0.39 | 1.34 | 0.65 | 0.15 | 0.32 | 1.3 | 0.27 |
| Interest | 0.13 | 0.19 | 0.12 | 0.11 | 0.15 | 0.06 | 0.07 | 0.06 | 0.08 | 0.17 | 0.18 | 0.29 | 0.48 |
| Depreciation | 0.21 | 0.21 | 0.21 | 0.24 | 0.22 | 0.23 | 0.24 | 0.38 | 0.25 | 0.25 | 0.81 | 0.9 | 0.8 |
| PBT | 0.39 | 0.52 | 0.58 | 1.5 | 0.63 | 0.79 | 1.01 | 1.91 | 1.03 | 1.23 | 2.36 | 1.12 | 0.65 |
| Tax % | −2.56% | 23.08% | 23.73% | 38.67% | 25.4% | 22.78% | 27.72% | 19.37% | 24.27% | 24.39% | 30.08% | 15.18% | 34.85% |
| Net Profit | 0.4 | 0.4 | 0.44 | 0.91 | 0.47 | 0.62 | 0.73 | 1.54 | 0.78 | 0.93 | 1.65 | 0.95 | 0.43 |
| EPS (₹) | 0.02 | 0.02 | 0.03 | 0.05 | 0.03 | 0.04 | 0.04 | 0.09 | 0.05 | 0.05 | 0.1 | 0.06 | 0.02 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7 | 13 | 29 | 42 | 40 | 40 | 51 | 74 | 74 | 80 | 115 | 182 | 215 |
| Expenses | 7 | 13 | 28 | 41 | 39 | 39 | 49 | 71 | 72 | 78 | 111 | 175 | 207 |
| Operating Profit | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 4 | 6 | 7 |
| OPM % | 1.8% | 1.7% | 2.4% | 2.2% | 1.7% | 3.1% | 3.2% | 4.2% | 3.7% | 2.8% | 3.2% | 3.4% | 3.4% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| PBT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 6 | 5 |
| Tax % | 27% | 29% | 28% | 20% | 15% | 29% | 26% | 28% | 28% | 28% | 22% | 25% | — |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 4 | 4 |
| EPS (₹) | 0.05 | 0.06 | 0.13 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 | 0.12 | 0.2 | 0.25 | 0.23 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 0.24 | 0.33 | 6 | 6 | 8 | 10 | 10 | 18 | 18 | 34 | 34 |
| Reserves | 0 | 0 | 1 | 5 | 6 | 7 | 6 | 6 | 24 | 25 | 54 | 57 |
| Borrowings | 0 | 1 | 1 | 5 | 5 | 5 | 7 | 5 | 5 | 2 | 2 | 18 |
| Other Liabilities | 1 | 1 | 11 | 4 | 1 | 2 | 6 | 7 | 12 | 3 | 5 | 11 |
| Total Liabilities | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 59 | 48 | 95 | 120 |
| Fixed Assets | 0 | 0 | 1 | 1 | 1 | 2 | 5 | 6 | 6 | 10 | 11 | 26 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 6 | 6 | 4 | 3 | 1 | 1 | 4 | 2 | 3 | 2 |
| Other Assets | 1 | 2 | 6 | 12 | 13 | 18 | 22 | 22 | 48 | 34 | 80 | 92 |
| Total Assets | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 59 | 48 | 95 | 120 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | −1 | −3 | −3 | −5 | −4 | 1 | 4 | −6 | 23 | −32 | −6 |
| Investing | 0 | 0 | −2 | 0 | 1 | 0 | −3 | −2 | −16 | 8 | 14 | −16 |
| Financing | 0 | 1 | 5 | 8 | −1 | 3 | 2 | −2 | 22 | −4 | 25 | 15 |
| Net Cash Flow | 0 | 0 | 0 | 5 | −5 | −1 | 0 | 0 | 0 | 27 | 6 | −6 |
| Free Cash Flow | 0 | −1 | −3 | −3 | −5 | −6 | −2 | 2 | −8 | 17 | −33 | −23 |
| CFO/EBITDA | 169 | −257 | −427 | −284 | −706 | −353 | 71 | 125 | −185 | 1,047 | −845 | −92 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 33 | 17 | 25 | 44 | 115 | 98 | 68 | 101 | 59 | 52 | 36 |
| Inventory Days | 22 | 14 | 63 | 19 | 51 | 34 | 46 | 34 | 39 | 80 | 90 | 97 |
| Days Payable | 66 | 27 | 79 | 9 | 12 | 20 | 46 | 39 | 56 | 8 | 13 | 22 |
| Cash Conversion Cycle | −4 | 20 | 1 | 35 | 84 | 129 | 98 | 63 | 83 | 131 | 129 | 111 |
| Working Capital Days | 5 | 9 | −29 | −1 | 84 | 105 | 77 | 58 | 94 | 132 | 158 | 93 |
| ROCE % | 28% | 18% | 37% | 10% | 4% | 4% | 5% | 9% | 6% | 8% | 5% | 6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ajooni Biotech insights
61 extracted metrics across FY15–FY27.
Documents
- 14 Aug 2026
- 14 Aug 2026
- 29 Jun 2026
- 28 May 2026
- 21 May 2026
- 4 May 2026
- 30 Jan 2026
- 8 Aug 2025
- 14 Jul 2025
- 15 May 2024
Frequently Asked Questions about Ajooni Biotech
What does Ajooni Biotech Ltd do?
Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.
Where is Ajooni Biotech Ltd (AJOONI) listed?
Ajooni Biotech Ltd trades as AJOONI on the NSE.
Which sector does Ajooni Biotech Ltd belong to?
Ajooni Biotech Ltd is classified under the FMCG sector, in the Food - Processing - Indian industry.
What is the PE ratio of Ajooni Biotech Ltd?
Ajooni Biotech Ltd trades at a PE ratio of 12.52 as of 4 Nov 2026, on earnings per share of ₹0.23, against a book value of ₹5.24 per share.
What is the 52-week high and low of Ajooni Biotech Ltd?
Over the last 52 weeks Ajooni Biotech Ltd has traded between ₹2.68 and ₹5.5 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Ajooni Biotech Ltd?
Ajooni Biotech Ltd reported a return on equity of 4.28%. Its debt-to-equity ratio is 0.20.
Company Information
Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AJOONI.md for Ajooni Biotech Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.